Clinical application of CORNEAL Phac55 refractive multifocal intraocular lens

Xu Qing,Zhou Huifang,Fan Xianqun
DOI: https://doi.org/10.3969/j.issn.1006-8422.2005.06.001
2005-01-01
Journal of Clinical Ophthalmology
Abstract:Objective To study the results of using CORNEAL Phac55 refractive multifocal intraocular lens (MIOL) for the aphakic eye after phacoemulsification(phaco). Methods The study comprised 60 randomly selected patients with age-related cataract from our hospital. After the phaco, CORNEAL DUAL525 single-focal intraocular lens (SIOL)was implanted into 30 eyes of 30 patients (SIOL group), while CORNEAL PhacS5 MIOL was implanted into 30 eyes of 30 patients (MIOL group). Visual acuity, corneal astigmatism and untoward visual symptoms were observed. Patients were being follow-up 6 to 12 months. Results The mean uncorrected near visual acuity was 0.58±0.27 in the MIOL group and 0.27±0.15 in the SIOL group, and the significantly statistical difference was found between these two groups on 6 months after surgery(P<0.01). There was no significantly statistical difference between the uncorrected distance visual acuity, corrected near visual acuity and corneal astigmatism of these two groups. None of the beth groups bothered by the severely photic phenomena. Conclusion CORNEAL Phac55 MIOL implantation is a safe and effective method for the aphakic eye after the phaco. MIOL has a distinct advantage in providing a full-distance visual acuity.
What problem does this paper attempt to address?